Report Code: A04258 | Pages: 150 | ||
Tables: 39 | Charts: 37 |
|
The Global Sanger’s Sequencing Service Market was valued at $192 million in 2013, and is estimated to reach at $1,085 million by 2025, registering a CAGR of 14.2% from 2018 to 2025. Sanger’s sequencing is one of the most pivotal techniques used by molecular biologists worldwide for sequence analysis. In this method, the target nucleic acid is reproduced several times, thereby making fragments of varying lengths.
Technological advancements in sequencing procedures, advantages associated with Sanger’s sequencing, and increase in genome mapping programs boost the growth of the global Sanger’s sequencing services market. Furthermore, rise in investment in R&D and increase in sequencing applications have supplemented the market growth.
However, lack of skilled professionals and standardization concerns associated with sequencing procedures hamper the growth of the industry. On the contrary, untapped potential of emerging markets and the use of cloud computing as a potential data management service are expected to provide lucrative opportunities for the market expansion.
The Sanger’s sequencing service market is segmented based on application, end user, and region. On the basis of application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and others. By end user, it is categorized into academic & government research institutes, pharmaceuticals companies, biotechnology companies and hospitals & clinics. Region wise, it is analyzed across the U.S., Europe, Japan, China, India, South-East Asia, and rest of the world (ROW).
The Sanger’s sequencing market share is dominated by the biomarkers & cancer segment, owing to their wide application in oncology research, biomarker discovery, and surge in prevalence of chronic diseases such as cancer.
Rise in focus of vendors on emerging markets, such as China, India, and Southeast Asia is expected to boost the market growth. China is projected to witness significant growth in the near future, owing to increase in R&D investment and surge in applications of Sanger’s sequencing. Furthermore, the Chinese region presents noteworthy opportunities for the venture capitalists and investors, as the developed markets are comparatively saturated.
The report provides extensive competitive analysis and profiles of the key market players such as Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Nucleics, SciGenom Labs Pvt. Limited, and Microsynth AG. Inc. The other players in the value chain (not included in the report) include Laragen, Inc. and StarSEQ GmbH.
Key Benefits for Stakeholders
Sangers Sequencing Service Market Report Highlights
Aspects | Details |
---|---|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Microsynth AG, Thermo Fisher Scientific Inc., LGC Science Group Holdings Limited, SciGenom Labs Pvt. Ltd., Fasteris SA, Quintara Biosciences, Source BioScience Plc, Nucleics Pty. Ltd., Genscript Biotech Corporation, GENEWIZ, Inc., GenHunter Corporation, CeMIA SA |
Loading Table Of Content...
Sanger's sequencing has enhanced diverse fields of life sciences through research innovation and development. Biomarker discovery, oncology studies, drug development, personalized genomics, and reproductive health are some of the widely known applications of this technique. Similarly, it has contributed significantly in agricultural & animal and forensic research. Sanger's sequencing services are anticipated to witness high adoption with increase in distinct applications and interventions, such as biomarker discovery, personalized medicine, and others. The market has gained momentum in the R&D sector, owing to increase in genome mapping projects globally. In addition, rise in awareness about Sanger's sequencing and its advantages drives the market.
The demand for Sanger's sequencing services has surged significantly due to reduced cost of sequencing and increase in total number of produced sequence reads per run. However, standardization concerns in diagnostics based on sequencing restrict the market growth. At present, academic & government research institutes are the largest end users of Sanger's sequencing services, followed by pharmaceutical companies, biotechnology companies, and hospitals & clinics. The biotechnology end-user segment is expected to exhibit the highest growth rate throughout the forecast period. However, the utilization of Sanger's sequencing is higher in academic & government research institutes as compared to other end users, as Sanger's sequencing services are routinely employed in hospitals for genomics research, biomarkers detection, and other purposes. The employment of technologically advanced Sanger's sequencing services is highest in the United States, owing to increase in adoption of services and technologies, followed by EU and Japan.
Start reading instantly.
This Report and over 71,229+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers